Filter
93
Filtered Results: 93
Text search:
Donnelly,
S
Featured
Recommendations
4
New Publications
13
Language
Document type
No document type
42
Guidelines
24
Studies & Reports
21
Manuals
2
Training Material
2
Situation Updates
1
Infographics
1
Countries / Regions
Global
5
Sierra Leone
4
Western and Central Europe
4
Guinea
2
Burkina Faso
2
Liberia
2
Uganda
2
Kenya
2
Ukraine
2
Latin America and the Carribbean
2
Eastern Europe
2
Russia
2
Senegal
1
Congo, Democratic Republic of
1
Mali
1
Ethiopia
1
Cameroon
1
Ghana
1
Niger
1
Zimbabwe
1
India
1
Nepal
1
South Sudan
1
Germany
1
Zambia
1
Rwanda
1
Indonesia
1
South Africa
1
Malawi
1
Eswatini/ Swaziland
1
Burundi
1
Lesotho
1
East and Southern Africa
1
West and Central Africa
1
Middle East and North Africa
1
South–East Asia Region
1
Venezuela
1
North America
1
France
1
Authors & Publishers
Publication Years
Category
Countries
13
Clinical Guidelines
8
Public Health
5
Women & Child Health
4
Pharmacy & Technologies
3
Key Resources
2
Capacity Building
1
Toolboxes
HIV
25
Mental Health
9
COVID-19
9
Planetary Health
5
Ebola
4
TB
3
Natural Hazards
2
Specific Hazards
2
Caregiver
2
NTDs
2
Health Financing Toolbox
2
NCDs
2
Disability
1
Refugee
1
Global Health Education
1
Social Ethics
1
Pharmacy
1
En el último decenio, los datos de las secuencias genéticas de los patógenos han adquirido un papel crucial en la detección y el manejo de los brotes de enfermedades infecciosas, contribuyendo al desarrollo de pruebas diagnósticas, medicamentos...
Bioethics 519 (online) doi:10.1111/bioe.12145 Volume 29 Number 8 2015 pp. 488–596;
Pandemic plans recommend phases of response to an emergent infectious disease (EID) outbreak, and are primarily aimed at preventing and mitigating human-to-human transmission. These plans carry presumptive weight ...
BACKGROUND: Growing political attention to antimicrobial resistance (AMR) offers a rare opportunity for achieving meaningful action. Many governments have developed national AMR action plans, but most have not yet implemented policy interventions to reduce antimicrobial overuse. A ...ystematic evidence map can support governments in making evidence-informed decisions about implementing programs to reduce AMR, by identifying, describing, and assessing the full range of evaluated government policy options to reduce antimicrobial use in humans.
METHODS AND FINDINGS: Seven databases were searched from inception to January 28, 2019, (MEDLINE, CINAHL, EMBASE, PAIS Index, Cochrane Central Register of Controlled Trials, Web of Science, and PubMed). We identified studies that (1) clearly described a government policy intervention aimed at reducing human antimicrobial use, and (2) applied a quantitative design to measure the impact. We found 69 unique evaluations of government policy interventions carried out across 4 of the 6 WHO regions. These evaluations included randomized controlled trials (n = 4), non-randomized controlled trials (n = 3), controlled before-and-after designs (n = 7), interrupted time series designs (n = 25), uncontrolled before-and-after designs (n = 18), descriptive designs (n = 10), and cohort designs (n = 2). From these we identified 17 unique policy options for governments to reduce the human use of antimicrobials. Many studies evaluated public awareness campaigns (n = 17) and antimicrobial guidelines (n = 13); however, others offered different policy options such as professional regulation, restricted reimbursement, pay for performance, and prescription requirements. Identifying these policies can inform the development of future policies and evaluations in different contexts and health systems. Limitations of our study include the possible omission of unpublished initiatives, and that policies not evaluated with respect to antimicrobial use have not been captured in this review.
CONCLUSIONS: To our knowledge this is the first study to provide policy makers with synthesized evidence on specific government policy interventions addressing AMR. In the future, governments should ensure that AMR policy interventions are evaluated using rigorous study designs and that study results are published.
A feasibility study in five African sites
The Global status report on violence prevention 2014, which reflects data from 133 countries, is the first report of its kind to assess national efforts to address interpersonal violence, namely child maltreatment, youth violence, intimate partner a...
Zanoni BC, et al. BMJ Glob Health 2016;1:e000004. doi:10.1136/bmjgh-2015-000004
UNAIDS/WHO 2015 | Reference
Oxfam Briefing Paper
Shoman et al. Globalization and Health (2017) 13:1 DOI 10.1186/s12992-016-0224-2
Mental, Neurological, and Substance Use Disorders: Disease Control Priorities, Third Edition (Volume 4).
Patel V, Chisholm D, Dua T, et al., editors.
Washington (DC): The International Bank for Reconstruction and Development / The World Bank; 20...
Emerging Infectious Diseases • www.cdc.gov/eid • Vol. 19, No. 9, September 2013
For COVID-19, as for many infectious diseases, the true level of transmission is frequently underestimated because a substantial proportion of people with the infection are undetected either because they are asymptomatic or have only mild ...ymptoms and thus typically fail to present at healthcare facilities. There may also be neglected or under-served segments of the population who are less likely to access healthcare or testing. Under-detection of cases may be exacerbated during an epidemic, when testing capacity may be limited and restricted to people with severe cases and priority risk groups (such as frontline healthcare workers, elderly people and people with comorbidities). Cases may also be misdiagnosed and attributed to other diseases with similar clinical presentation, such as influenza.
Differences in mortality between groups of people and countries are important proxy indicators of relative risk of death that guide policy decisions regarding scarce medical resource allocation during the ongoing COVID-19 pandemic. This document is intended to help countries estimate CFR and, if possible, IFR, as appropriately and accurately as possible, while accounting for possible biases in their estimation
This summary assesses the current state of evidence on each approach in tabular form, providing: the definition and objectives; evidence of effectiveness; operational considerations (e.g., training,...
Human schistosomiasis, a parasitic and often chronic illness, is one of the major neglected tropical diseases worldwide. It is estimated that 240 million people suffer from ...chistosomiasis, with more than 200000 fatalities recorded each year. Schistosomiasis is caused by an infection of the blood fluke Schistosoma and is transmitted to humans through direct contact with infected water.
Mapping Report - Ireland.
Eur Respir J 2016; 48: 808–817 | DOI: 10.1183/13993003.00840-2016
